The 2026 Medical Aesthetics AI Visibility Index
5W Public Relations, a notable independent PR and digital marketing agency in the U.S., has collaborated with Haute MD, a prominent luxury editorial network, to release the first-ever Medical Aesthetics AI Visibility Index for 2026. This comprehensive report marks the ninth installment in the AI Visibility Index series and focuses specifically on the $22 billion medical aesthetics space.
The index is designed to rank the leading 25 brands in the field based on AI citation share gleaned from major platforms like ChatGPT, Claude, Perplexity, and Google AI Overviews. In total, the report analyzed over 60 consumer queries related to various aspects of medical aesthetics, such as neurotoxins, dermal fillers, energy-based devices, and medical-grade skincare products.
Key Findings
1.
Top Brands: According to the index, Botox, Juvéderm, CoolSculpting, SkinCeuticals, and Morpheus8 have established themselves as the top brands, collectively commanding a significant portion of AI citation share across multiple categories. This indicates a strong online presence and recognition in patient discovery channels.
2.
Market Share: The leading 15 brands dominate the AI citation share, collectively acquiring around 62% of the total visibility, while the remaining 38% is distributed among brands ranked from 16 to 25, non-ranked brands, and specific citations linked to practices of dermatologists and plastic surgeons.
3.
Emerging Trends: The growing popularity of GLP-1 weight-loss medications is reshaping consumer demands in the aesthetics market. There is a noticeable shift towards body contouring, skin tightening, and facial volume restoration, which is also reflected in changing AI citation patterns.
4.
Decline of Social Media: Traditional channels for patient referrals, particularly social media platforms like Instagram and TikTok, are seeing a decline in effectiveness. Instead, AI platforms are stepping in as the primary resource for consumers researching aesthetic procedures and providers.
Industry Significance
Ronn Torossian, the founder of 5WPR, remarked on the rapid evolution within the medical aesthetics field, pointing out that it has become the most dynamic healthcare sub-category concerning AI behaviors. The discrepancy in performance between marketing expenditure and AI visibility is strikingly apparent. Brands that have thrived on influencer-driven discovery via platforms like Instagram are now facing challenges as those old channels begin to falter. Successful brands are those that now regard AI citations as vital infrastructure.
Guidance for Stakeholders
The report not only presents rankings but also offers valuable strategic insights for various stakeholders in the medical aesthetics market. Manufacturers, medical-grade skincare brands, and practitioner networks are encouraged to consider how they can effectively leverage their market positions to increase their AI citation shares. The role of clinical authorities, peer-reviewed research, and high-profile editorials is crucial in shaping output from large language models (LLMs) that inform patient choices.
For those interested in a more in-depth understanding of these industry dynamics, the full Medical Aesthetics AI Visibility Index for 2026 can be accessed at
Haute MD.
About the Organizations
Haute MD is a leading editorial platform that connects consumers with board-certified dermatologists, plastic surgeons, and aesthetic practitioners, serving as a go-to resource for ultra-high-net-worth individuals exploring aesthetic options.
5WPR has established its reputation in the industry for innovative PR and digital marketing strategies over the past two decades. The agency remains committed to delivering impactful communications for businesses in diverse sectors, with accolades from various industry organizations recognizing its excellence.
Conclusion
The 2026 Medical Aesthetics AI Visibility Index shines a light on the rapidly changing landscape of aesthetic medicine, emphasizing the growing importance of AI visibility in shaping patient preferences and influencing industry success.